Indication

Carcinoma of breast

Carcinoma of the breast is a malignant epithelial neoplasm that originates in the glandular structures of the breast tissue, predominantly arising from the lining of the lactiferous ducts (ductal carcinoma) or the milk-producing lobules (lobular carcinoma). Read more about Carcinoma of breast

105 drugs 64 manufacturers

Advertisement

Drugs that treat it

Common Carcinoma of breast therapies.

Showing 37–45 of 105 drugs

THIOTEPA

CARCINOMA OF BREAST·+6
WEST-WARD,INC.

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES·RETINOBLASTOMA·+17
ROXANE/WEST-WAR

DOXORUBICIN HCL

ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
APP/FRESENIUS K
Filter & compare in the drug finder →Opens the drug finder with Carcinoma of breast preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Carcinoma of breast.

Carcinoma of the breast is a malignant epithelial neoplasm that originates in the glandular structures of the breast tissue, predominantly arising from the lining of the lactiferous ducts (ductal carcinoma) or the milk-producing lobules (lobular carcinoma).

It predominantly affects adult females, though it can also occur in males.

Pathophysiologically, the disease is characterized by unregulated epithelial proliferation that may remain confined to the basement membrane as carcinoma in situ or breach surrounding tissue planes as invasive disease, carrying the potential to disseminate via regional lymphatic channels and hematogenous pathways to distant organs.

Clinically, it frequently presents as a painless, palpable breast mass, focal tissue thickening, or abnormal findings on screening mammography, with advanced presentations occasionally demonstrating nipple retraction, skin dimpling, or spontaneous nipple discharge.

Personalize your experience

Follow Carcinoma of breast and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it